Report cover image

Global Biosimilar Market, by Drug Class Sizing and Forecast till 2035

Publisher Market Research Future
Published Jan 16, 2025
Length 23 Pages
SKU # RESFT21159681

Description

Global Biosimilar Market, by Drug Class Sizing and Forecast till 2035 delivers an in-depth analysis of drug classes including monoclonal antibodies and key biologics such as adalimumab and trastuzumab.

The report also highlights innovation trends, therapeutic relevance, and product pipelines, making it a detailed resource for understanding segment-wise dynamics.

Table of Contents

23 Pages
1 Global Biosimilar Market, By Drug Class
1.1 Overview
1.2 Monoclonal Antibodies
1.2.1 Adalimumab
1.2.2 Infliximab
1.2.3 Rituximab
1.2.4 Bevacizumab
1.2.5 Trastuzumab
1.2.6 Ustekinumab
1.2.7 Tocilizumab
1.2.8 Aflibercept
1.2.9 Dupilumab
1.2.10 Denosumab
1.2.11 Others
1.3 Insulin
1.4 Granulocyte Colony- Stimulating Factor
1.5 Erythropoietin
1.6 Recombinant Human Growth Hormone
1.7 Etanercept
1.8 Follitropin
1.9 Teriparatide
1.10 Anticoagulants
Data Citations
Disclaimers
List Of Tables
Table 1 Global Biosimilar Market, By Drug Class, 2019–2032 (Usd Million)
Table 2 Global Biosimilar Market, For Monoclonal Antibodies, By Region, 2019–2032 (Usd
Million)
Table 3 Global Biosimilar Market, For Monoclonal Antibodies, By Type, 2019–2032 (Usd
Million)
Table 4 Global Biosimilar Market, For Adalimumab, By Region, 2019–2032 (Usd Million)
Table 5 Global Biosimilar Market, For Infliximab, By Region, 2019–2032 (Usd Million)
Table 6 Global Biosimilar Market, For Rituximab, By Region, 2019–2032 (Usd Million)
Table 7 Global Biosimilar Market, For Bevacizumab, By Region, 2019–2032 (Usd Million)
Table 8 Global Biosimilar Market, For Trastuzumab, By Region, 2019–2032 (Usd Million)
Table 9 Global Biosimilar Market, For Ustekinumab, By Region, 2019–2032 (Usd Million)
Table 10 Global Biosimilar Market, For Tocilizumab, By Region, 2019–2032 (Usd Million)
Table 11 Global Biosimilar Market, For Aflibercept, By Region, 2019–2032 (Usd Million)
Table 12 Global Biosimilar Market, For Dupilumab, By Region, 2019–2032 (Usd Million)
Table 13 Global Biosimilar Market, For Denosumab, By Region, 2019–2032 (Usd Million)
Table 14 Global Biosimilar Market, For Others, By Region, 2019–2032 (Usd Million)
Table 15 Global Biosimilar Market, For Insulin, By Region, 2019–2032 (Usd Million)
Table 16 Global Biosimilar Market, For Granulocyte Colony- Stimulating Factor, By
Region, 2019–2032 (Usd Million)
Table 17 Global Biosimilar Market, For Erythropoietin, By Region, 2019–2032 (Usd
Million)
Table 18 Global Biosimilar Market, For Recombinant Human Growth Hormone, By
Region, 2019–2032 (Usd Million)
Table 19 Global Biosimilar Market, For Etanercept, By Region, 2019–2032 (Usd Million)
Table 20 Global Biosimilar Market, For Follitropin, By Region, 2019–2032 (Usd Million)
Table 21 Global Biosimilar Market, For Teriparatide, By Region, 2019–2032 (Usd Million)
Table 22 Global Biosimilar Market, For Anticoagulants, By Region, 2019–2032 (Usd
Million)
Table 23 Global Biosimilar Market, For Others, By Region, 2019–2032 (Usd Million)
List Of Figures
Figure 1 Global Biosimilar Market, By Drug Class, Segment Attractiveness Analysis
Figure 2 Global Biosimilar Market, Monoclonal Antibodies, By Type Segment
Attractiveness, 2023 2032 (Usd Million)
Figure 3 Global Biosimilar Market, By Drug Class, 2023 2032 (Usd Million)
Figure 4 Global Biosimilar Market Share (%), By Drug Class, 2023 10

Search Inside Report

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us